ALGS
Aligos Therapeutics Inc
Price:  
34.07 
USD
Volume:  
315,780.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aligos WACC - Weighted Average Cost of Capital

The WACC of Aligos Therapeutics Inc (ALGS) is 7.4%.

The Cost of Equity of Aligos Therapeutics Inc (ALGS) is 7.40%.
The Cost of Debt of Aligos Therapeutics Inc (ALGS) is 5.00%.

Range Selected
Cost of equity 6.40% - 8.40% 7.40%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 8.4% 7.4%
WACC

Aligos WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 8.40%
Tax rate 0.10% 0.20%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 8.4%
Selected WACC 7.4%